Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.
- Status
- COMPLETED
- Phase
- PHASE3
Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood
- Status
- TERMINATED
- Phase
- PHASE2
Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Velcade® and Bone Formation in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2
S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma
- Status
- COMPLETED
- Phase
- NA
Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
UARK 2003-41: A Study of High-Dose Density Therapy in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2